ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3216

Integrated High-Dimensional Analyses Reveal a Pathologically Expanded ‘Peripheral’ B Cell-Helper T Cell Population in Rheumatoid Arthritis

Deepak Rao1, Michael Gurish2, Kamil Slowikowski3, Chamith Fonseka2, Jennifer Marshall4, Yanyan Liu5, Laura T. Donlin6, Lauren Henderson7, Fumitaka Mizoguchi8, Nikola Teslovich9, Michael Weinblatt10, Elena Massarotti10, Jonathan Coblyn11, Simon M. Helfgott10, Yvonne C. Lee12, Derrick J. Todd10, Vivian P. Bykerk13, Susan M. Goodman14, Alessandra B. Pernis15, Lionel Ivashkiv14, Elizabeth W. Karlson10, Peter Nigrovic9, Andrew Filer16, Christopher Buckley17, James Lederer18, Soumya Raychaudhuri19 and Michael Brenner1, 1Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Division of Rheumatology, Immunology, Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Divisions of Rheumatology and Genetics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 6Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 7Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 8Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 9Brigham and Women's Hospital and Harvard Medical School, Cambridge, MA, 10Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 11Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 12Rheumatology Immunology & Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 13Divison of Rheumatology, Hospital for Special Surgery, New York, NY, 14Medicine, Hospital for Special Surgery, New York, NY, 15David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 16University of Birmingham, Birmingham, United Kingdom, 17Rheumatology, University of Birmingham, Birmingham, United Kingdom, 18Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 19Brigham and Women's Hospital, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: CyTOF, plasma cells, rheumatoid arthritis (RA) and synovial cells, synovial fluid, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 16, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis II

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Determining the pathologic functions of T cells that infiltrate target tissues remains a central challenge in autoimmune diseases. In rheumatoid arthritis (RA), the formation of T cell-B cell aggregates and differentiation of plasma cells within synovium suggest a pathologic role for synovial T cells with B cell-helper function. The prevailing view considers CD4+ T follicular helper (Tfh) cells, identified as PD-1+ CXCR5+, as the principal T cell population capable of promoting B cell differentiation. However, Tfh cell migration is largely restricted to secondary lymphoid organs. It is thus difficult to reconcile the lymphoid-homing migratory patterns of Tfh cells with the development of T cell-B cell aggregates in inflamed synovium.

Methods: We used mass cytometry and multidimensional flow cytometry to interrogate T cells that express markers of activation, including PD-1, MHC II, CD69, CD25, and CD38, in synovial tissue, synovial fluid, and blood from patients with seropositive RA and other inflammatory arthritides. Sorted PD-1hi T cells from blood and synovial samples were analyzed by RNAseq, RT-PCR, intracellular flow cytometry, and in vitro B cell helper assays. Synovial tissue was also evaluated by immunofluorescence microscopy.

Results: Mass cytometric analysis of seropositive RA synovial tissue cells revealed a strikingly expanded population of PD-1hi CXCR5– CD4+ T cells, which constituted ~25% of synovial CD4+ T cells and outnumbered Tfh cells by 8-fold. PD-1hi CXCR5– cells were similarly enriched in synovial fluid from patients with seropositive RA, but not seronegative inflammatory arthritides. PD-1hi CXCR5– cells, but not Tfh cells, were also expanded in the circulation of seropositive, but not seronegative, RA patients and decreased with DMARD therapy. Surprisingly, these cells were not exhausted, but instead highly expressed factors that enable B cell help, including IL-21, CXCL13, ICOS, SAP, and MAF. Like Tfh cells, PD-1hi CXCR5– cells from synovial tissue, synovial fluid, and blood induced plasma cell differentiation in vitro, which was blocked by neutralization of IL-21 or SLAMF5. However, RNAseq transcriptomics robustly separated circulating PD-1hi CXCR5– cells from Tfh cells. Compared to Tfh cells, PD-1hi CXCR5– cells expressed high levels of chemokine receptors that direct migration to inflamed sites, such as CCR2, CX3CR1, and CCR5, and a decreased Bcl6/Blimp1 ratio. Flow cytometry confirmed CCR2 expression on ~50% of synovial PD-1hi CXCR5– T cells. By microscopy, PD-1hi CXCR5– T cells were frequently found adjacent to B cells in RA synovium.

Conclusion: We suggest that PD-1hi CXCR5– T cells represent a T peripheral helper (Tph) cell population, analogous to T follicular helper (Tfh) cells, that supports B cell responses in non-lymphoid tissues. Given their marked expansion in seropositive RA, these cells may be important in driving pathologic B cell responses and autoantibody production.


Disclosure: D. Rao, None; M. Gurish, None; K. Slowikowski, None; C. Fonseka, None; J. Marshall, None; Y. Liu, None; L. T. Donlin, None; L. Henderson, None; F. Mizoguchi, None; N. Teslovich, None; M. Weinblatt, None; E. Massarotti, None; J. Coblyn, None; S. M. Helfgott, None; Y. C. Lee, None; D. J. Todd, None; V. P. Bykerk, None; S. M. Goodman, None; A. B. Pernis, None; L. Ivashkiv, None; E. W. Karlson, None; P. Nigrovic, None; A. Filer, None; C. Buckley, None; J. Lederer, None; S. Raychaudhuri, None; M. Brenner, None.

To cite this abstract in AMA style:

Rao D, Gurish M, Slowikowski K, Fonseka C, Marshall J, Liu Y, Donlin LT, Henderson L, Mizoguchi F, Teslovich N, Weinblatt M, Massarotti E, Coblyn J, Helfgott SM, Lee YC, Todd DJ, Bykerk VP, Goodman SM, Pernis AB, Ivashkiv L, Karlson EW, Nigrovic P, Filer A, Buckley C, Lederer J, Raychaudhuri S, Brenner M. Integrated High-Dimensional Analyses Reveal a Pathologically Expanded ‘Peripheral’ B Cell-Helper T Cell Population in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/integrated-high-dimensional-analyses-reveal-a-pathologically-expanded-peripheral-b-cell-helper-t-cell-population-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/integrated-high-dimensional-analyses-reveal-a-pathologically-expanded-peripheral-b-cell-helper-t-cell-population-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology